Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial

被引:14
作者
Damery, Sarah [1 ]
Smith, Steve [2 ]
Clements, Alison [3 ]
Holder, Roger [1 ]
Nichols, Linda [1 ]
Draper, Heather [1 ]
Clifford, Sue [1 ]
Parker, Laura [1 ]
Hobbs, Richard [3 ]
Wilson, Sue [1 ]
机构
[1] Univ Birmingham, Edgbaston B15 2TT, W Midlands, England
[2] Univ Hosp Coventry & Warwickshire NHS Trust, Univ Hosp, Coventry CV2 2DX, W Midlands, England
[3] Univ Oxford, Dept Primary Hlth Care Sci, Oxford OX1 2ET, England
来源
TRIALS | 2012年 / 13卷
关键词
Colorectal cancer; General practitioner; Screening; FOBt; Uptake; Non-responder; Randomised controlled trial; Qualitative; Endorsement; COLORECTAL-CANCER; PRIMARY-CARE; INTERVENTIONS; EDUCATION; SURVIVAL; IMPACT;
D O I
10.1186/1745-6215-13-18
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The success and cost-effectiveness of bowel cancer screening depends on achieving and maintaining high screening uptake rates. The involvement of GPs in screening has been found to improve patient compliance. Therefore, the endorsement of screening by GPs may increase uptake rates amongst non-responders. Methods/Design: A two-armed randomised controlled trial will evaluate the effectiveness of a GP endorsed reminder in improving patient participation in the NHS Bowel Cancer Screening Programme (NHSBCSP). Up to 30 general practices in the West Midlands with a screening uptake rate of less than 50% will be recruited and patients identified from the patient lists of these practices. Eligible patients will be those aged 60 to 74, who have previously been invited to participate in bowel screening but who have been recorded by the Midlands and North West Bowel Cancer Screening Hub as non-responders. Approximately 4,380 people will be randomised in equal numbers to either the intervention (GP letter and duplicate FOBt kit) or control (no additional contact) arms of the trial. The primary outcome measure will be the difference in the uptake rate of FOBt screening for bowel cancer between the intervention and control groups at 13 weeks after the GP endorsed reminder and duplicate FOBt kit are sent. Secondary outcome measures will be subgroup analyses of uptake according to gender, age and deprivation quartile, and the validation of methods for collecting GP, NHSBCSP and patient costs associated with the intervention. Qualitative work (30 to 40 semi-structured interviews) will be undertaken with individuals in the intervention arm who return a FOBt kit, to investigate the relative importance of the duplicate FOBt kit, reminder to participate, and GP endorsement of that reminder in contributing to individuals' decisions to participate in screening. Discussion: Implementing feasible, acceptable and cost-effective strategies to improve screening uptake amongst non-responders to invitations to participate is fundamentally important for the success of screening programmes. If this feasibility study demonstrates a significant increase in uptake of FOBt screening in individuals receiving the intervention, a definitive, appropriately powered future trial will be designed.
引用
收藏
页数:7
相关论文
共 30 条
[1]  
[Anonymous], HLTH TECHNOL ASSESS
[2]   Improving preventive care by prompting physicians [J].
Balas, EA ;
Weingarten, S ;
Garb, CT ;
Blumenthal, D ;
Boren, SA ;
Brown, GD .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (03) :301-308
[3]   Improving attendance for breast screening among recent non-attenders: a randomised controlled trial of two interventions in primary care [J].
Bankhead, C ;
Richards, SH ;
Peters, TJ ;
Sharp, DJ ;
Hobbs, FDR ;
Brown, J ;
Roberts, L ;
Tydeman, C ;
Redman, V ;
Formby, J ;
Wilson, S ;
Austoker, J .
JOURNAL OF MEDICAL SCREENING, 2001, 8 (02) :99-105
[4]   Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities [J].
Barrett, J ;
Jiwa, M ;
Rose, P ;
Hamilton, W .
FAMILY PRACTICE, 2006, 23 (01) :15-19
[5]   Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study [J].
Berrino, Franco ;
De Angelis, Roberta ;
Sant, Milena ;
Rosso, Stefano ;
Lasota, Magdalena B. ;
Coebergh, Jan W. ;
Santaquilani, Mariano .
LANCET ONCOLOGY, 2007, 8 (09) :773-783
[6]   Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner [J].
Cole, SR ;
Young, GP ;
Byrne, D ;
Guy, JR ;
Morcom, J .
JOURNAL OF MEDICAL SCREENING, 2002, 9 (04) :147-152
[7]  
Coleman M, 2008, SPEARHEAD PCTS COMPA
[8]   Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001 [J].
Coleman, MP ;
Rachet, B ;
Woods, LM ;
Mitry, E ;
Riga, M ;
Cooper, N ;
Quinn, MJ ;
Brenner, H ;
Estève, J .
BRITISH JOURNAL OF CANCER, 2004, 90 (07) :1367-1373
[9]  
Department of Health, 2011, IMPR OUTC STRAT CANC
[10]  
Ellins J., 2005, ENGAGED ARE PEOPLE T